Financhill
Back

Sinovac Biotech Quote, Financials, Valuation and Earnings

Sinovac Biotech Price Quote

$6.47

Sinovac Biotech Key Stats

Sell
47
Sinovac Biotech (SVA) is a Sell

Day range:
$6.47 - $6.47
52-week range:
$6.25 - $6.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.50
P/B ratio:
0.05%

Volume:
0
Avg. volume:
0
1-year change:
0%
Market cap:
$464.9M
Revenue:
$448.3M
EPS:
$-1.31

How Much Does Sinovac Biotech Make?

Is Sinovac Biotech Growing As A Company?

  • What Is Sinovac Biotech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.04%
  • What Is Sinovac Biotech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 3.8%

Sinovac Biotech Stock Price Performance

  • Did Sinovac Biotech Stock Go Up Last Month?
    Sinovac Biotech share price went up by 0% last month
  • Did SVA's Share Price Rise Over The Last Year?
    SVA share price rose by 0% over the past 1 year

What Is Sinovac Biotech 52-Week High & Low?

Sinovac Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sinovac Biotech?

  • How Much Debt Does Sinovac Biotech Have?
    Total long term debt quarterly is $309.7M
  • How Much Cash Does Sinovac Biotech Have?
    Cash and short term investments quarterly total is $10.6B
  • What Is Sinovac Biotech’s Book Value Per Share?
    Book value per share is 120.36

Is Sinovac Biotech Cash Flow Positive?

Data Unavailable

Sinovac Biotech Return On Invested Capital

  • Is Management Doing A Good Job?
    SVA return on invested capital is -1.02%
  • What Is Sinovac Biotech Return On Assets?
    ROA measures how assets are converting to revenues and is -0.93%
  • What Is SVA Return On Equity?
    ROE is a measure of profitability and is -1.05%

Sinovac Biotech Earnings Date & Stock Price

Sinovac Biotech Competitors

  • Who Are Sinovac Biotech's Competitors?
    Below is a list of companies who compete with Sinovac Biotech or are related in some way:
    • Adagene Inc (ADAG)
    • CASI Pharmaceuticals Inc (CASI)
    • LakeShore Biopharma Co Ltd (LSB)
    • China SXT Pharmaceuticals Inc (SXTC)
    • Zai Lab Ltd (ZLAB)

Sinovac Biotech Dividend Yield

Sinovac Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 380% -50%
Revenue: 303.71% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many SVA shares are owned by institutional investors?
    27.2M SVA shares are owned by institutional investors
  • How many SVA shares are owned by insiders?
    0 SVA shares are owned by insiders